Clinical Supply Development Gene Immune Response 
pharmaphorum
NOVEMBER 2, 2022
billion on offer in milestones if the programmes meet development and commercial objectives. According to a statement from the two companies, Arcturus will contribute its STARR self-amplifying mRNA vaccine and LUNAR lipid nanoparticle delivery platform, which has already been deployed in the development of COVID-19 vaccine ARCT-154.
Drug Discovery World
NOVEMBER 3, 2022
Paul Viggers , Chief Commercial Officer at TrakCel, explains how it fits into the drug discovery and development sector. . Ten years ago, cell and gene therapy (CGT) was really finding its feet as success stories such as that of Emily Whitehead began to hit the news. The impact for COS developers . The catalysts .
Expert insights. Personalized for you.
52 
Let's personalize your content